Skip to Main Content

Paper Details

Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
BMC Cancer
4
2022
ALL, Acute Lymphoblastic Leukaemia, Cancer, Children, Pediatric, Pediatric acute lymphoblastic leukemia, Pre-B cell immunophenotype, TRT, VTE, bone toxicity, cancer, children, neurotoxicity, pancreatitis, patients, pediatric, pediatric acute lymphoblastic leukemia, venous thrombosis
Author NameAffiliation
Peter DownieMonash Children's Hospital
Glenn M MarshallSchool of Clinical Medicine
Glenn M MarshallKids Cancer Centre, Sydney Children's Hospital
Glenn M MarshallChildren's Cancer Institute, Lowy Cancer Research Centre
Marion K MateosSchool of Clinical Medicine
Marion K MateosKids Cancer Centre, Sydney Children's Hospital
Marion K MateosChildren's Cancer Institute, Lowy Cancer Research Centre
  • 1 - 7

Datasets

Release 1.2